In an Mdr2 −/− mice model of PBC, anti-BAFF mAb (SANDY-2) treatment reshaped hepatic B-cell receptor (BCR) repertoire and reduced the titer of the autoantibody antinuclear antibody (ANA) and the levels of its immune complexes. Here, TNFSF13B is linked to primary biliary cholangitis.